Yuji Hiromatsu
Kurume, 8308577, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Teprotumumab-associated persistent unilateral hearing loss in dysthyroid optic neuropathy: a case report with review of the literature.
Journal: Endocrine journal
Published: July 01, 2026
Quality of life and psychosocial well-being in thyroid eye disease in Japan: pre-teprotumumab national survey.
Journal: Journal of the Endocrine Society
Published: January 24, 2026
Reduction in extraocular muscle and orbital fat volumes after teprotumumab treatment in Japanese patients with thyroid eye disease: an exploratory magnetic resonance imaging analysis from the OPTIC-J trial.
Journal: Japanese journal of ophthalmology
Published: October 17, 2025
Corrigendum to "A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients" The Lancet Regional Health-Western Pacific, Volume 55 (2025), 101464.
Journal: The Lancet regional health. Western Pacific
Published: July 03, 2025
Development of Thyrotoxicosis With Positive TSH Receptor Antibody and Transition to Hypothyroidism in a Patient With Unresectable Hepatocellular Carcinoma During Combined Atezolizumab and Bevacizumab Therapy: A Case Report and Review of the Literature.
Journal: The Kurume medical journal
Published: June 15, 2025
Transition from hypothyroidism to Graves' disease, development of thyroid eye disease, progression to optic neuropathy after inpatient pulse therapy, and long-term administration of outpatient pulse therapy: a case report with review of literature.
Journal: Endocrine journal
Published: September 25, 2024
A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients.
Journal: The Lancet regional health. Western Pacific
Published: July 26, 2024
Enzyme-linked immunosorbent assay of 3 Screen Islet Cell Autoantibody in patients with autoimmune thyroid disease.
Journal: World journal of diabetes
Published: January 27, 2024
Development of type 1 diabetes in a patient treated with anti-interleukin-6 receptor antibody for rheumatoid arthritis.
Journal: Journal of diabetes investigation
Published: September 13, 2021
Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes.
Journal: World journal of diabetes
Published: February 03, 2021
Graves' Disease after Adrenalectomy for Cushing's Syndrome.
Journal: Internal medicine (Tokyo, Japan)
Published: September 07, 2020
Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody-positive by bridging-type enzyme-linked immunosorbent assay.
Journal: Journal of diabetes investigation
Published: March 24, 2020
Last Updated: 09/26/2026